176 related articles for article (PubMed ID: 37977433)
1. Polygenic risk scores for Alzheimer's disease in relation to cognitive change: A representative sample from the general population followed over 16 years.
Najar J; Thorvaldsson V; Kern S; Skoog J; Waern M; Zetterberg H; Blennow K; Skoog I; Zettergren A
Neurobiol Dis; 2023 Dec; 189():106357. PubMed ID: 37977433
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals.
Pettigrew C; Nazarovs J; Soldan A; Singh V; Wang J; Hohman T; Dumitrescu L; Libby J; Kunkle B; Gross AL; Johnson S; Lu Q; Engelman C; Masters CL; Maruff P; Laws SM; Morris JC; Hassenstab J; Cruchaga C; Resnick SM; Kitner-Triolo MH; An Y; Albert M
Alzheimers Res Ther; 2023 Mar; 15(1):66. PubMed ID: 36978190
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score.
Tomassen J; den Braber A; van der Lee SJ; Reus LM; Konijnenberg E; Carter SF; Yaqub M; van Berckel BNM; Collij LE; Boomsma DI; de Geus EJC; Scheltens P; Herholz K; Tijms BM; Visser PJ
BMC Neurol; 2022 Dec; 22(1):484. PubMed ID: 36522743
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E moderates the association between non-APOE polygenic risk score for Alzheimer's disease and aging on preclinical cognitive function.
Xu Y; Sun Z; Jonaitis E; Deming Y; Lu Q; Johnson SC; Engelman CD
Alzheimers Dement; 2024 Feb; 20(2):1063-1075. PubMed ID: 37858606
[TBL] [Abstract][Full Text] [Related]
5. Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.
Pyun JM; Park YH; Lee KJ; Kim S; Saykin AJ; Nho K;
Transl Neurodegener; 2021 Aug; 10(1):32. PubMed ID: 34465370
[TBL] [Abstract][Full Text] [Related]
6. Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals.
Xu Y; Vasiljevic E; Deming YK; Jonaitis EM; Koscik RL; Van Hulle CA; Lu Q; Carboni M; Kollmorgen G; Wild N; Carlsson CM; Johnson SC; Zetterberg H; Blennow K; Engelman CD
J Alzheimers Dis; 2023; 94(4):1587-1605. PubMed ID: 37482996
[TBL] [Abstract][Full Text] [Related]
7. Prediction of clinical diagnosis of Alzheimer's disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years.
Stocker H; Perna L; Weigl K; Möllers T; Schöttker B; Thomsen H; Holleczek B; Rujescu D; Brenner H
Mol Psychiatry; 2021 Oct; 26(10):5812-5822. PubMed ID: 32404947
[TBL] [Abstract][Full Text] [Related]
8. Dissociable influences of
Ge T; Sabuncu MR; Smoller JW; Sperling RA; Mormino EC;
Neurology; 2018 May; 90(18):e1605-e1612. PubMed ID: 29592889
[TBL] [Abstract][Full Text] [Related]
9. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
[TBL] [Abstract][Full Text] [Related]
10. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
Klages JD; Fisk JD; Rockwood K
Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
[TBL] [Abstract][Full Text] [Related]
11. Association of
Xicota L; Gyorgy B; Grenier-Boley B; Lecoeur A; Fontaine G; Danjou F; Gonzalez JS; Colliot O; Amouyel P; Martin G; Levy M; Villain N; Habert MO; Dubois B; Lambert JC; Potier MC;
Neurology; 2022 Aug; 99(5):e462-e475. PubMed ID: 35606148
[TBL] [Abstract][Full Text] [Related]
12. Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease.
Darst BF; Koscik RL; Racine AM; Oh JM; Krause RA; Carlsson CM; Zetterberg H; Blennow K; Christian BT; Bendlin BB; Okonkwo OC; Hogan KJ; Hermann BP; Sager MA; Asthana S; Johnson SC; Engelman CD
J Alzheimers Dis; 2017; 55(2):473-484. PubMed ID: 27662287
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndrome.
Gorijala P; Aslam MM; Dang LT; Xicota L; Fernandez MV; Sung YJ; Fan KH; Feingold E; Surace EI; Chhatwal JP; Hom CL; ; ; Hartley SL; Hassenstab J; Perrin RJ; Mapstone M; Zaman SH; Ances BM; Kamboh MI; Lee JH; Cruchaga C
Alzheimers Dement; 2024 Feb; 20(2):1038-1049. PubMed ID: 37855447
[TBL] [Abstract][Full Text] [Related]
14. The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study.
Gharbi-Meliani A; Dugravot A; Sabia S; Regy M; Fayosse A; Schnitzler A; Kivimäki M; Singh-Manoux A; Dumurgier J
Alzheimers Res Ther; 2021 Jan; 13(1):5. PubMed ID: 33397450
[TBL] [Abstract][Full Text] [Related]
15. Digital Clock Drawing as an Alzheimer's Disease Susceptibility Biomarker: Associations with Genetic Risk Score and APOE in Older Adults.
Thompson LI; Cummings M; Emrani S; Libon DJ; Ang A; Karjadi C; Au R; Liu C
J Prev Alzheimers Dis; 2024; 11(1):79-87. PubMed ID: 38230720
[TBL] [Abstract][Full Text] [Related]
16. A Non-APOE Polygenic Risk Score for Alzheimer's Disease Is Associated With Cerebrospinal Fluid Neurofilament Light in a Representative Sample of Cognitively Unimpaired 70-Year Olds.
Skoog I; Kern S; Najar J; Guerreiro R; Bras J; Waern M; Zetterberg H; Blennow K; Zettergren A
J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):983-990. PubMed ID: 33512503
[TBL] [Abstract][Full Text] [Related]
17. Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in aging.
Supiyev A; Karlsson R; Wang Y; Koch E; Hägg S; Kauppi K
Neurobiol Aging; 2023 Jun; 126():103-112. PubMed ID: 36965205
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
[TBL] [Abstract][Full Text] [Related]
19. A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease.
Porter T; Burnham SC; Savage G; Lim YY; Maruff P; Milicic L; Peretti M; Ames D; Masters CL; Martins RN; Rainey-Smith S; Rowe CC; Salvado O; Taddei K; Groth D; Verdile G; Villemagne VL; Laws SM
Front Aging Neurosci; 2018; 10():423. PubMed ID: 30620773
[TBL] [Abstract][Full Text] [Related]
20. Polygenic risk scores for Alzheimer's disease are related to dementia risk in APOE ɛ4 negatives.
Najar J; van der Lee SJ; Joas E; Wetterberg H; Hardy J; Guerreiro R; Bras J; Waern M; Kern S; Zetterberg H; Blennow K; Skoog I; Zettergren A
Alzheimers Dement (Amst); 2021; 13(1):e12142. PubMed ID: 33532541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
